Kevin Bitterman

Creates biotech companies de novo around breakthrough science, typically from academic research. Focuses on novel drug modalities and first-in-class therapeutics.

Partner at Atlas Venture, a Boston-based biotech venture firm focused exclusively on company creation in life sciences. Former biotech entrepreneur. Atlas has created over 30 biotech companies from scratch.